CX 2020 LIVE: Overwhelming 91% of specialist audience favours venous stents
A poll of an enthused audience of venous specialists during the CX 2020 LIVE Deep Venous Disease Consensus session found that 91% of them were in...
ABRE study meets primary safety and effectiveness endpoints
Medtronic has announced the first-ever results from the ABRE clinical study assessing the safety and effectiveness of the investigational Abre venous self-expanding stent system...
CX 2020 LIVE addresses latest developments in superficial venous disease
For the first venous session of CX 2020 LIVE, 759 attendees from 79 different countries tuned in. Each audience member could submit their name,...
FDA clears Transit Scientific’s XO Score PTA scoring sheath platform
Transit Scientific has received US Food and Drug Administration (FDA) clearance for the XO Score percutaneous transluminal angioplasty (PTA) scoring sheath platform for use...
